Novaccess Global Inc Net Income per Employee (XSNX), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Novaccess Global Inc  (NONE: XSNX)
 

Novaccess Global Inc Net Income per Employee

XSNX's Quarterly Results, Trends, Rankings, Statistics
Novaccess Global Inc's Income per employee grew in the fourth quarter 2024 on a trailing twelve month basis to $ 1,178,266, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 368 other companies achieving higher income per employee. While Novaccess Global Inc's total ranking has deteriorated compared to the previous quarter from 3930 to 4182.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XSNX Net Income per Employee (Sep 30 2024)
IV. Quarter		 (Jun 30 2024)
III. Quarter		 (Mar 31 2024)
II. Quarter		 (Dec 31 2023)
I. Quarter		 (Sep 30 2023)
IV. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 1,178,266 -1,892,999 -1,736,305 -834,188 -4,769,187
XSNX's Total Ranking # 4182 # 3930 # 2075 # 2315 # 2910
Seq. Net Income Change - - - - -

XSNX Company Profile >> Back to XSNX Efficiency Comparisons >> Compare XSNX Net Income per Employee to its Competitors

XSNX Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 369
Healthcare Sector # 835
Overall Market # 4182

Net Income per Employee Statistics
High Average Low
$ 4,255,998 $ -1,928,178 $ -10,026,549
(Jun 30 2019)   (Jun 30 2021)







Companies with similar Income per Employee for 12 month ending Sep 30 2024, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2024Number of Employees Sep 30 2024
Siga Technologies Inc  1,749,173.96 $ 85.710  Million 49 
Protagonist Therapeutics inc   1,294,310.61 $ 170.849  Million 132 
Agios Pharmaceuticals Inc   1,248,718.52 $ 674.308  Million 540 
Novaccess Global Inc  1,178,266.00 $ 1.178  Million 1 
Keenova Therapeutics Plc  1,168,500.00 $ 1,869.600  Million 1,600 
Glucotrack Inc   994,333.33 $ 14.915  Million 15 
Ligand Pharmaceuticals Incorporated  962,638.30 $ 45.244  Million 47 
Exelixis Inc   930,104.62 $ 1,066.830  Million 1,147 
Halozyme Therapeutics Inc   927,817.97 $ 392.467  Million 423 
Tenax Therapeutics Inc   910,036.38 $ 14.561  Million 16 
Entrada Therapeutics Inc   873,342.11 $ 132.748  Million 152 
Silexion Therapeutics Corp  847,785.71 $ 11.869  Million 14 
Prestige Consumer Healthcare Inc   829,687.72 $ 472.922  Million 570 
United Therapeutics Corporation  793,500.00 $ 1,110.900  Million 1,400 
Catalyst Pharmaceuticals Inc   784,598.90 $ 142.797  Million 182 
Third Harmonic Bio Inc   739,584.91 $ 39.198  Million 53 
Engene Therapeutics Inc   672,463.41 $ 55.142  Million 82 


Date modified: 2026-09-02T21:11:03+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.